Executive Function and CBT Skills Training for Schizophrenia
(E-CBSST Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this research study to test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training (E-CBSST). The aims include determining whether E-CBSST is feasible and increases Cognitive Behavioral Social Skills Training (CBSST) Skills Learning to a level that will lead to a clinically meaningful improvement in functioning.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that your antipsychotic medication dosage has not changed in the four weeks before starting the study.
What data supports the effectiveness of the treatment E-CBSST for schizophrenia?
Research shows that Cognitive Behavioral Social Skills Training (CBSST), a component of E-CBSST, improves functioning in people with schizophrenia compared to standard care alone. Additionally, CBSST has been found to enhance social function, especially in patients with more severe executive dysfunction, indicating its potential benefit in improving life skills for those with schizophrenia.12345
Is Executive Function and CBT Skills Training for Schizophrenia safe for humans?
The studies on Cognitive Behavioral Social Skills Training (CBSST) and its variations, like CBSST-CCT, suggest that these interventions are generally safe for people with schizophrenia. Participants in these studies did not report significant safety concerns, and the interventions were deemed acceptable, with no modifications needed to the procedures.12367
How is the E-CBSST treatment different from other treatments for schizophrenia?
E-CBSST is unique because it combines executive function training with Cognitive-Behavioral Social Skills Training (CBSST), specifically targeting cognitive deficits and social skills in people with schizophrenia. This approach is designed to improve both cognitive abilities and social functioning, which are often impaired in schizophrenia, making it different from standard treatments that may not address these areas as comprehensively.12348
Research Team
Tarek Rajji, MD
Principal Investigator
Centre for Addiction and Mental Health
Eric Granholm, PhD
Principal Investigator
University of California, San Diego
Eligibility Criteria
This trial is for individuals with schizophrenia, psychosis, or schizoaffective disorder. Participants should be interested in a new therapy that combines cognitive and behavioral skills training with exercises to improve thinking and decision-making.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Executive Function Training
Participants undergo a 2-week Executive Function Training course with 3 sessions per week of computerized exercises and strategy monitoring
E-CBSST Cycle 1
Participants complete the first cycle of E-CBSST with 18 sessions, delivered twice a week, including brief EFT at the start of CBSST group sessions
E-CBSST Cycle 2
Participants complete the second cycle of E-CBSST with another 18 sessions, delivered twice a week, including brief EFT at the start of CBSST group sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- E-CBSST (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
Dr. Christopher Longhurst
University of California, San Diego
Chief Medical Officer since 2021
MD and MS in Medical Informatics from UC Davis
Patty Maysent
University of California, San Diego
Chief Executive Officer since 2016
MBA from Stanford University
Centre for Addiction and Mental Health
Collaborator
Dr. Catherine Zahn
Centre for Addiction and Mental Health
Chief Executive Officer since 2009
MD, University of Toronto
Dr. James Graham
Centre for Addiction and Mental Health
Chief Medical Officer since 2024
PhD in Functional Neuroimaging